Desk›Healthcare› Supriya Lifescience Ltd
Supriya Lifescience Ltd
BSE 543434 · NSE SUPRIYA · ISIN INE07RO01027 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹803.75
+3.55%
BSE close, 28 August 2026
₹6,468.81 cr
8.0 cr shares · Small cap
₹2,049.93 cr
as published
32.6× · 7.14×
EPS ₹24.65 · BV ₹112.57
827.88 / 209.12
₹ cr, as filed
25
5 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -26.0% |
|---|---|
| Against 52-week low | +47.3% |
| Day change | +3.55% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹24.65 |
|---|---|
| Price / earnings | 32.61× |
| Price / book | 7.14× |
| Book value — derived, price ÷ P/B | ₹112.57 |
| Return on equity | 21.90% |
| Operating margin | 26.41% |
| Net margin | 12.67% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 21.90%
- ROE as published
- 21.90%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 189.75 | 24.04 | 2.99 | 26.41% | 12.67% |
| Mar-26 · Q | 276.53 | 74.23 | 9.22 | 36.56% | 26.84% |
| FY25-26 | 827.88 | 209.12 | 25.98 | 36.85% | 25.26% |
Quarter on quarter
- Revenue, quarter on quarter
- -31.4%
- Net profit, quarter on quarter
- -67.6%
- Operating margin, quarter on quarter
- -1,015 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 4 |
| Newspaper Publication | 4 |
| AGM / EGM | 3 |
| Analyst / Investor Meet | 3 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Postal Ballot | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 5 selected · busiest 2026-08-13
Filing rhythm · the twelve most recent
2026-09-012026-10-08
SelectedProcedural
Filings
25 in the window · 4 earlier on record
-
8 October 2026 ·
Announcement Under Regulation 30 Of SEBI(LODR) Regulations, 2015.
Enclosed herewith is the announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
Company Update / General View filing →
-
28 September 2026 ·
Closure of Trading Window
The Intimation of closure of window for trading in securities of the Company by Designated Persons and their Immediate relatives for the quarter and half year ending on September 30, 2026, ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report for 18th Annual General meeting is attached herewith.
AGM/EGM / AGM View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM along with Proceedings, Scrutinizer Report and Voting Results is attached herewith.
AGM/EGM / AGM View filing →
-
23 September 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Enclosed herewith is the announcement under Regulation 30 of SEBI (LODR), 2015. Kindly take the same on record.
Company Update / General View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investor/ Analyst Call is enclosed herewith. Kindly take the same on record.
Company Update / Analyst / Investor Meet View filing →
-
2 September 2026 ·
Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company
Enclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered. Kindly take the same on record.
Company Update / General View filing →
-
2 September 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Enclosed herewith disclosure under Regulation 30.
Company Update / General View filing →
-
2 September 2026 ·
Newspaper Publication
Copy of Newspaper Public for dispatch of AGM Notice and Annual Report.
Company Update / Newspaper Publication View filing →
-
1 September 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
1 September 2026 ·
Notice Of 18Th Annual General Meeting Of The Company.
Notice of 18th AGM of the Company.
AGM/EGM / AGM View filing →
-
1 September 2026 ·
-
27 August 2026 ·
Newspaper Publication
Copy of Newspaper Publication is enclosed.
Company Update / Newspaper Publication View filing →
-
26 August 2026 ·
Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26.
Enclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.
Corp. Action / Record Date View filing →
-
18 August 2026 ·
Earnings Call Transcript
Earnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed.
Company Update / Earnings Call Transcript View filing →
-
14 August 2026 ·
Analyst / Investor Meet - Outcome
Audio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30, 2026 is enclosed.
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026 ·
Newspaper Publication
Enclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Press Release / Media Release
Press Release for Unaudited Financial Results for quarter ended June 30, 2026 is enclosed herewith.
Company Update / Press Release / Media Release View filing →
-
13 August 2026 ·
Investor Presentation
Investor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30,2026 is enclosed herewith.
Company Update / Investor Presentation View filing →
-
13 August 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026.
Unaudited Financial Results for the quarter ended June 30, 2026 is enclosed.
Result / Financial Results View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 13, 2026
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held ....
Board Meeting / Outcome of Board Meeting View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is enclosed herewith.
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
Board Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026
Supriya Lifescience Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve In terms of Regulation ....
Board Meeting / Board Meeting View filing →
-
23 July 2026 ·
Newspaper Publication
Please find attached copy of Newspaper Publication of Postal Ballot Notice.
Company Update / Newspaper Publication View filing →
-
21 July 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
AGM/EGM / Postal Ballot View filing →
RSS feed for Supriya Lifescience Ltd · the 50 most recent filings